Infertility. Female infertility of other origin
Conditions
Interventions
Intervention 1: Intervention group: Two tablets of letrozole 2.5 mg(Aboureihan pharmaceutical) will be used from second day of induction ovulation and continued for five days then induction continued
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: IVF Candidate History of endometriosis
Exclusion criteria
Exclusion criteria: pathologic lesion in endometrial cavity pathologic lesion in endometrial cavity; hypersensitivity to letrozole; liver disease liver disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: At the day of triggering(5days after ending intervention). Method of measurement: By vaginal ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: BhCG test.;Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Visualisation fetal heart rate by vaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Davari Tanha
Tehran University of Medical Sciences
Outcome results
None listed